These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 25943292
1. Severe osteogenesis imperfecta Type-III and its challenging treatment in newborn and preschool children. A systematic review. Sinikumpu JJ, Ojaniemi M, Lehenkari P, Serlo W. Injury; 2015 Aug; 46(8):1440-6. PubMed ID: 25943292 [Abstract] [Full Text] [Related]
3. Update on the evaluation and treatment of osteogenesis imperfecta. Harrington J, Sochett E, Howard A. Pediatr Clin North Am; 2014 Dec; 61(6):1243-57. PubMed ID: 25439022 [Abstract] [Full Text] [Related]
5. New trends in the treatment of osteogenesis imperfecta type III - own experience. Jakubowska-Pietkiewicz E, Chlebna-Sokół D. Ortop Traumatol Rehabil; 2008 Sep; 10(6):593-601. PubMed ID: 19153548 [Abstract] [Full Text] [Related]
6. Management of lower limb deformities in children with osteogenesis imperfecta. Kaur S, Kulkarni KP, Kochar IS, Narasimhan R. Indian Pediatr; 2011 Aug; 48(8):637-9. PubMed ID: 21719942 [Abstract] [Full Text] [Related]
9. Treatment of children with osteogenesis imperfecta. Rauch F, Glorieux FH. Curr Osteoporos Rep; 2006 Dec; 4(4):159-64. PubMed ID: 17112427 [Abstract] [Full Text] [Related]
10. Therapy with pamidronate in children with osteogenesis imperfecta. Marginean O, Tamasanu RC, Mang N, Mozos I, Brad GF. Drug Des Devel Ther; 2017 Dec; 11():2507-2515. PubMed ID: 28894358 [Abstract] [Full Text] [Related]
11. Long-term follow-up in osteogenesis imperfecta type VI. Trejo P, Palomo T, Montpetit K, Fassier F, Sato A, Glorieux FH, Rauch F. Osteoporos Int; 2017 Oct; 28(10):2975-2983. PubMed ID: 28689307 [Abstract] [Full Text] [Related]
12. The management of osteogenesis imperfecta in adults: state of the art. Lafage-Proust MH, Courtois I. Joint Bone Spine; 2019 Oct; 86(5):589-593. PubMed ID: 30742929 [Abstract] [Full Text] [Related]
14. [Osteogenesis imperfecta as an interdisciplinary medical problem]. Popko J, Galicka A, Wołczyński S, Zalewski W, Konstantynowicz J. Chir Narzadow Ruchu Ortop Pol; 2004 Oct; 69(4):235-9. PubMed ID: 15587378 [Abstract] [Full Text] [Related]
15. Osteogenesis imperfecta in children and adolescents-new developments in diagnosis and treatment. Trejo P, Rauch F. Osteoporos Int; 2016 Dec; 27(12):3427-3437. PubMed ID: 27492436 [Abstract] [Full Text] [Related]
17. Modern approach to children with osteogenesis imperfecta. Zeitlin L, Fassier F, Glorieux FH. J Pediatr Orthop B; 2003 Mar; 12(2):77-87. PubMed ID: 12584489 [Abstract] [Full Text] [Related]
18. Controlled trial of pamidronate in children with types III and IV osteogenesis imperfecta confirms vertebral gains but not short-term functional improvement. Letocha AD, Cintas HL, Troendle JF, Reynolds JC, Cann CE, Chernoff EJ, Hill SC, Gerber LH, Marini JC. J Bone Miner Res; 2005 Jun; 20(6):977-86. PubMed ID: 15883638 [Abstract] [Full Text] [Related]
19. Recent progress in diagnosis and treatment of osteogenesis imperfecta. Moriwake T, Seino Y. Acta Paediatr Jpn; 1997 Aug; 39(4):521-7. PubMed ID: 9316304 [Abstract] [Full Text] [Related]
20. Intravenous Bisphosphonate Therapy of Young Children With Osteogenesis Imperfecta: Skeletal Findings During Follow Up Throughout the Growing Years. Palomo T, Fassier F, Ouellet J, Sato A, Montpetit K, Glorieux FH, Rauch F. J Bone Miner Res; 2015 Dec; 30(12):2150-7. PubMed ID: 26059976 [Abstract] [Full Text] [Related] Page: [Next] [New Search]